Similarly, progress in PDGFR signaling in glioma would greatly benefit from an in vivo model that is based on clinically relevant parameters such as overexpression of PDGFRα and its chronic stimulation by PDGF-A ligand. This evidence concerns the gene PDGFRB and central nervous system cancer.